Grifols Launches Evanzys IH to Revolutionize Transfusion Medicine Laboratories
Grifols has introduced Evanzys IH, an automated system aimed at enhancing efficiency in transfusion medicine labs. This launch aligns with the growing demand for advanced, scalable laboratory workflows.
Theia Market Signal Identification - AI Assisted
Grifols has announced the launch of Evanzys IH, a next-generation automated system for immunohematology sample analysis, enhancing laboratory efficiency and flexibility. The introduction occurred during the International Society of Blood Transfusion (ISBT) Congress in Kuala Lumpur, Malaysia, running until June 24, 2026.
This modular system aims to optimize lab operations, reduce manual tasks, and provide faster transfusion results. The launch reinforces Grifols' commitment to R&D and its leadership in blood screening solutions. The company is also presenting Total Lab Automation capabilities and other innovations at ISBT 2026, indicating a significant shift toward integrated automation in transfusion medicine.
Comments